Barely Significant
← all excerpts

CD4 cell response to interval therapy with natalizumab.

Ann Clin Transl Neurol · 2015 · PMC4435710 · PMID 26000328

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantP < 0.001actually significant
The results of the rmANOVA revealed that the within-subject effect (comparing different states of natalizumab use) was highly significant ( F = 38.665, P < 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.